Clindamycin Palmitate Hydrochloride
Spezifikationen
25507-04-4CAS-Nummer
607-740-9EG-Nummer
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochlorideIUPAC-Name
C34H64Cl2N2O6SChemische Formel
699.9 g/molMolekulargewicht
CLINDAMYCIN PALMITATE HYDROCHLORIDE; Clindamycin palmitate HCl; 25507-04-4; Cleocin Pediatric; DTXSID3048734; Clindamycin 2-palmitate hydrochloride; VN9A8JM7M7; U-25,179 E; NSC-759141; U-25179E; U-25179-E; DTXCID0028660; RefChem:54849; Clindamycin Palmitate Hydrochloride (pediatric); Clindamycin palmitate (hydrochloride); [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride; C34H64Cl2N2O6S; UNII-VN9A8JM7M7; NCGC00185773-02; 25507-04-4 (palmitate HCl); U 25179E; (2R,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl palmitate; SCHEMBL41416; Clindamycin palmitate hydrochloride [USAN:USP:JAN]; orb1685660; CHEMBL1200632; NIOSH/GF2450000; CHEBI:34647; HY-B1454R; GTNDZRUWKHDICY-DJHAJVGHSA-N; GLXC-23173; MSK166862A; HY-B1454; Tox21_113175; MFCD09752824; MSK166862A-100M; AKOS030242182; CCG-270385; NSC 759141; (2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yl palmitate hydrochloride; AS-58470; Clindamycin-2-palmitate, monohydrochloride; Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-palmitate monohydrochloride; CAS-25507-04-4; C4534; CS-0013162; GF24500000; T6449; Clindamycin palmitate hydrochloride (JAN/USP); D01990; F20748; Clindamycin palmitate (hydrochloride) (Standard); CLINDAMYCIN PALMITATE HYDROCHLORIDE [JAN]; CLINDAMYCIN PALMITATE HYDROCHLORIDE [MART.]; CLINDAMYCIN PALMITATE HYDROCHLORIDE [USAN]; CLINDAMYCIN PALMITATE HYDROCHLORIDE [VANDF]; CLINDAMYCIN PALMITATE HYDROCHLORIDE [USP-RS]; CLINDAMYCIN PALMITATE HYDROCHLORIDE [WHO-DD]; Q27291919; CLINDAMYCIN PALMITATE HYDROCHLORIDE [ORANGE BOOK]; CLINDAMYCIN PALMITATE HYDROCHLORIDE [USP MONOGRAPH]; Clindamycin palmitate hydrochloride Solution in Methanol, 100ug/mL; [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate;hydrochloride; L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-2-HEXADECANOATE, MONOHYDROCHLORIDE, (2S-TRANS)-; L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, monohydrochloride, (2S-trans)-; Methyl 7-chloro-6,7,8-trideoxy-2-O-hexadecanoyl-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside--hydrogen chloride (1/1); METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE 2-PALMITATE MONOHYDROCHLORIDESynonyme
Produkte, die Clindamycin Palmitate Hydrochloride enthalten
Clindamycin Palmitate hydrochloride GranulesClindamycin Palmitate - Lupin LtdClindamycin Palmitate - ViatrisClindamycin Palmitate - Transo-Pharm USA LLCClindamycin Palmitate - Pfizer IncClindamycin Palmitate - Nuray Chemicals Private LimitedClindamycin PalmitateClindamycin Palmitate HCLClindamycin Palmitate Hydrochloride
